New Guidelines on Managing Hyperglycemia in Type 2 Diabetes Announced

The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) has announced updated guidelines on how to …

Expert Advice: Avoiding a Low While Behind the Wheel

Of the nearly 100 million Americans living with diabetes or prediabetes, a large percentage will seek a driver’s license or are already …

Lilly’s Investigational Two-in-One Diabetes Drug Shows Positive Results

Eli Lilly and Company’s investigational two-in-one diabetes drug showed both meaningful blood sugar reduction and significant weight loss in …

Weight Loss Drug Shows Positive Effect on Diabetes

A weight loss drug, lorcaserin, was found to reduce the risk of diabetes by 19 percent in patients with prediabetes in a recent study. The drug is …

Link Between Hypoglycemia and Dementia Further Elucidated

Severe hypoglycemia has much more serious consequences in people who have both diabetes and dementia than those with diabetes alone, according to new …

Tresiba® for Children with Type 1 diabetes Approved in Canada

Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada. …

Novo Nordisk to Roll Out “Smart” Insulin Pens in 2019

Novo Nordisk announced plans to launch its first “smart” insulin pens next year. In addition, to integrate it smartpens with broader …

Gene Variant May Predispose Latinos to Both Type 2 Diabetes and Low Body Weight

A well-known gene variant linked to Type 2 diabetes may also predispose people to have lower body weight, new research finds. The contradictory …

Lipid‐Lowering Medication Decreases Risk of Diabetic Retinopathy in Type 2 Diabetes

Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients …

Abbott’s FreeStyle® Libre 2 Secures CE Mark for Use in Europe

People living with diabetes in Europe will now have the choice to be alerted in real-time of hypoglycemia (low glucose levels) or hyperglycemia …